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Marek’s disease virus (MDV) is an alphaherpesvirus that causes T cell lymphoma and severe immunosuppression in
chickens. The MDV UL49 gene, which encodes the tegument viral protein 22 (VP22), has been expressed as a green
fluorescent protein (GFP) fusion protein in chicken embryonic fibroblasts to examine its subcellular localization. As with both
human herpesvirus 1 and bovine herpesvirus 1VP22-GFP fusion proteins, the MDV VP22-GFP product binds to microtubules
and heterochromatin. In addition, the MDV protein also binds to the centrosomes. During mitosis, VP22-GFP binds to sister
chromatids, but dissociates from the centrosomes and the microtubules of the mitotic spindle. A series of VP22 carboxy
terminal truncation mutants were constructed to define regions responsible for these binding properties. These mutants
identified separable domains or motifs responsible for binding microtubules and heterochromatin. © 2002 Elsevier ScienceKey Words: herpesvirus; Marek’s disease virus; viral protein; VP22; GFP; localization.INTRODUCTION
Marek’s disease virus (MDV) is a highly virulent onco-
genic herpesvirus of chicken that causes severe immu-
nosuppression and T cell lymphoma (Venugopal, 2000).
Based upon its genomic sequence, MDV is a member of
the alphaherpesvirus family which includes the human
herpesviruses (HHV1, 2, and 3), bovine herpesvirus 1
(BHV1), and several other herpesviruses (Roizman and
Sears, 1996). Members of this family show extensive
conservation of their genomic organization and more
than 50 homologous genes are readily identified in the
comparison of MDV with HHV1 (Lee et al., 2000; Tulman
et al., 2000). The structure of the herpesvirus particle is
also conserved within this family. The virions are com-
posed of three layers: a capsid containing the genome,
an amorphous tegument layer surrounding the capsid,
and a membranous envelope (Cho et al., 1999). Most of
the structural proteins that comprise these layers also
exhibit significant structural and functional homology be-
tween the different members of alphaherpesvirus family.
One of the tegument structural proteins that is con-
served among the alphaherpesviruses is Virus Protein
22 (VP22). The HHV1 and BHV1 VP22 proteins exhibit
several properties when expressed in cells, including
association with microtubules, heterchromatin, and chro-
matids. HHV1, BHV1, and Marek’s disease virus VP22 are
capable of intercellular transport (Dorange et al., 2000;
Elliott and O’Hare, 1997; Harms et al., 2000) and MDV
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235VP22 has been shown to bind DNA (Dorange et al.,
2000). Analysis of the sequence of VP22 reveals little
similarity to any known cellular protein suggesting it
uses unique means to interact with cellular structures
and for intercellular transport (Dorange et al., 2000).
To study the specific subcellular localization of MDV
VP22 and provide tools to study its relationship to MDV
infection, we have constructed green fluorescent protein
(GFP) chimeras with VP22. GFP has proven to be an excel-
lent and accurate reporter of subcellular localization when
fused to a variety of herpesvirus proteins (Bello et al., 1999;
Brideau et al., 1998; Degreve et al., 1999; Desai and Person,
1998; Loimas, et al., 1998; Lomonte and Everett, 1999; Soli-
man and Silverstein, 2000; Yamada et al., 1999; Zhu et al.,
1999) including VP22 (Dorange et al., 2000; Elliott and
O’Hare, 1997, 1999a,b, 2000; Harms et al., 2000). All of the
properties observed with HHV1 VP22 have also been ob-
served with GFP-VP22 fusion proteins (Dorange et al., 2000;
Elliott and O’Hare, 1997, 1999a,b, 2000; Harms et al., 2000).
Consequently, we have used fusion proteins between MDV-
VP22 and GFP to determine the subcellular localization of
MDV-VP22. As with HHV1 and BHV1 VP22, MDV VP22 is
localized to microtubules and the nucleus. Within the nu-
cleus, MDV VP22 appeared bound to heterochromatin. Dur-
ing mitosis, MDV VP22 associates with chromatids, but is
absent from the microtubules of the spindle. In addition,
MDV VP22 binds to centrosomes and also appears to bind
the midbody that connects daughter cells following mitosis.
Finally, we have constructed a series of carboxy terminal
truncation mutations that demonstrate dissociation of mi-
crotubule, nuclear, and centrosome localization.
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VP22 interacts with components of the microtubule
network
Marek’s disease virus VP22 was cloned in frame with
the coding sequence of the green fluorescent protein
(GFP) and the subcellular localization of the resulting
fusion protein was determined by confocal microscopy.
The VP22-GFP encoding plasmid was transfected into
secondary chicken embryonic fibroblasts. VP22-GFP ex-
pressed protein was found in both the cytoplasmic and
nuclear compartments. Within the cytoplasm, VP22-GFP
exhibited at least two distinct, specific patterns (Fig. 1).
Typically, it formed a filamentous network reminiscent of
microtubules. It also exhibited a punctuate pattern with
multiple spots of different sizes. This differs dramatically
from the cytoplasmic distribution of GFP alone, which is
found diffusely throughout the cytoplasm, with no evi-
dence of filaments or punctuate distribution.
To characterize further the subcellular localization of
VP22-GFP, transfected cells were fixed, incubated with
anti-alpha-tubulin antibodies, and then visualized with
Texas red conjugated anti-mouse IgG. As seen in Fig.
1a–c, filamentous VP22 green fluorescence was found to
localize with the microtubules. Typically, much of the
cytoplasmic VP22-GFP formed a continuous network
with the microtubules. The VP22-GFP giving rise to punc-
tuate fluorescence is presumably aggregated fusion pro-
tein. These aggregates were typically in close approxi-
mation to the microtubule network. In some cells, VP22-
GFP protein was also found in a perinuclear spot that
appeared as part of the centrosome (Fig. 1d–f). Staining
transfected cells using anti-gamma tubulin, which is found
in centrosomes (Dictenberg et al., 1998; Moritz et al., 1995;
Oakley et al., 1990), supported this conclusion (Fig. 1e). In
some instances, this VP22 appeared to be composed of
two distinct spots, suggesting association with individual
centrosomes (Fig. 1f). VP22-GFP also appeared on some,
but not all microtubules, radiating from these centrosomes.
In several cases, VP22-GFP associated with the nuclear
envelope appeared more concentrated in a region opposite
the centrosome and then decreased in a gradient radiating
from this location. (Fig. 1d).
MDV VP22 interacts with heterochromatin and
chromatids
In addition to the cytoplasm, MDV VP22-GFP was also
found within the nucleus (Fig. 1). Staining experiments
with heterochromatin binding Hoechst 33342 revealed
localization of nuclear MDV VP22-GFP to the heterochro-
matin (Fig. 1g–i). This contrasts with the nuclear distri-
bution of GFP alone, which is distributed diffusely in the
nucleus, although it is excluded from the nucleoli.
While the MDV VP22-GFP fusion protein was found
both within the nucleus and associated with microtu-
bules in interphase cells, in mitotic cells the fusion pro-tein was only found associated with the chromatids (Fig.
1j). No VP22-GFP was found associated with the mitotic
spindle. In postmitotic cells, VP22-GFP appeared bound
to a microtubular structure, possibly the midbody, con-
necting the two daughter cells (Fig. 1k).
Mutations dissociate nuclear and microtubule binding
A series of carboxy terminal mutations were con-
structed to begin defining regions responsible for the
VP22-properties (Table 1, Fig. 2). These truncations indi-
cate that the microtubule, heterochromatin, and centro-
some binding domains are separable. The truncation
mutants D214 and D183 exhibit the properties of wild-
type VP22 and bind microtubules, heterochromatin, and
centrosomes (Fig. 2a–b). The D171 carboxy terminal trun-
cation binds heterochromatin and centrosomes (Fig. 2c).
However, it does not form filamentous structures and
appears to have lost its ability to interact with microtu-
bules. Another truncation, D144, binds centrosomes, but
not longer interacts with either heterochromatin or mi-
crotubules (Fig. 2d). The centrosomal localization in all of
these mutants indicates that the expressed VP22 protein
is not simply denatured, but retains some folded struc-
ture.
Sequence alignment
Given that MDV, HHV1, and BHV1 share similar prop-
erties, comparison of the amino acid sequences and
predicted secondary structures, combined with results
from the mutation studies, may help define motifs re-
sponsible for these properties. Figure 3 shows a plot of
similarity for these three proteins as a function of amino
acid position. There is a notable lack of similarity
throughout the amino and carboxy terminal regions of
the VP22 proteins. A core region, corresponding to MDV
VP22 amino acids 94–180, exhibits significant conserva-
tion of both primary amino acid sequence and predicted
secondary structure (Fig. 3). Analysis with the program
MAST, which identifies potentially unique motifs in mul-
tiple sequence alignments, identified three potential mo-
tifs within the aligned VP22 proteins. All three predicted
motifs fall within the core sequence, and two are located
within a region apparently important for binding hetero-
TABLE 1
Effect of Deletion Mutations on VP22 Binding Properties
Deletion Microtubules Heterochromatin Centrosome
D214 and D183 1 1 1
D171 2 1 1
D144 2 2 1chromatin.
with the midbody.
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As with human herpesvirus 1 (HHV1) and bovine her-
pesvirus (BHV), VP22, the MDV VP22 protein exhibits
multiple distinct patterns of subcellular localization (Dor-
FIG. 2. Distribution of carboxy terminal deletion mutants of VP22-
GFP. (a) Carboxy terminal deletion mutant D214, showing both hetero-
chromatin and centriole binding. (b) Mutant D183VP22-GFP showing
assoication with microtubule structures. (c) D171VP22-GFP showing
heterochromatin association in nucleus. (d) D144VP22-GFP showing
association with the centriole.FIG. 1. Distribution of VP22-GFP. (a–c) CEF cells were transfected with
VP22-GFP and replated onto microscope slides. Cells were incubated with
anti-alpha-tubulin antibody and then stained with Texas red anti-mouse
IgG. (a) Bundled microtubules stained red in a cell expressing VP22-GFP.
Contrast with thickness of microtubules in surrounding cells. (b) VP22-GFP
fluorescence showing similarity to the distribution of tubulin. (c) Composite
image of panels a and b. (d) Nuclear and centrosomal localization of
VP22-GFP. VP22-GFP fluorescence showing association with the centro-
some, filaments, and the nucleus. (e) Centrosomal localization of VP22-
GFP (arrow). Anti-gamma tubulin combined with Texas red conjugated
anti-mouse IgG was used to label centrosomes of CEF cells transfected
with VP22-GFP. (f) Centrosomal GFP-VP22 appearing as two spots (arrow).
(g–i) VP22-GFP associates with heterochromatin. CEF cells transfected
with VP22-GFP were stained with Hoechst 33342 to reveal heterochroma-
tin. (g) Hoechst 33342 staining. (h) VP22-GFP. (i) Composite of panels g and
h. Note extensive colocalization of nuclear VP22-GFP and the heterochro-
matin stain. (j) VP22-GFP associates with mitotic chromatids. Composite
image of a CEF cell expressing VP22-GFP and stained for tubulin. Note
association of VP22-GFP with chromatids, but its absence from the mitotic
spindle. (k) VP22-GFP links the nuclei of two cells by apparent associationange et al., 2000; Elliott and O’Hare, 1997, 1998; Elliott et
confer
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demonstrates that MDV VP22-GFP expressed in chicken
embryonic fibroblasts by transfection localizes to micro-
tubules, nuclei, mitotic chromatids, and the centrosome.
Furthermore, the carboxy terminal deletion series dem-
onstrates that the microtubular, nuclear, and centrosome
localization are separable, arguing these properties are
attributes of independent VP22 domains or motifs.
The interaction of MDV VP22 with microtubules is
similar to that reported for HHV1 and BPV proteins.
Microtubules with bound MDV VP22-GFP appeared both
rearranged and thicker relative to surrounding cells not
expressing the fusion protein (Fig. 1). This is consistent
with reports that human herpesvirus VP22 causes acet-
ylation, bundling, and stabilization of cellular microtu-
FIG. 3. Conservation of VP22. (a) A plot of the similarity of herpe
herpesvirus 1 (EHV1), human herpesvirus 3 (HHV3), bovine herpesvirus
Alignment of VP22 protein sequences from the core region (see text). P
microtubule indicate that loss of the region bounded by the mutationsbules (Elliott and O’Hare, 1998). Cells containing thesethick microtubules decorated with MDV VP22-GFP have
frequently lost their centrosome as has been seen with
VP22 encoded by other herpesviruses. The role of this
VP22 activity during viral infection is uncertain and the
BHV VP22 gene is dispensible for in vitro passage of the
virus (Liang et al., 1995). During early stages of infection,
herpesvirus capsids bind microtubules for transport to
the nucleus. (Granzow et al., 1997; Sodeik et al., 1997).
Perhaps the ability of VP22 to bind and bundle microtu-
bules plays an important role in this step of the herpes-
virus replicative cycle.
The nuclear VP22-GFP appears localized predomi-
nantly to the heterochromatin. This is consistent with the
reports of Dorange et al. (2000) that VP22 is capable of
directly binding DNA. In mitotic cells, MDV VP22-GFP
VP22 protein. Sequences aligned were derived from MDV1, equine
1), human herpesvirus 2 (HHV2), and human herpesvirus 1 (HHV1). (b)
s of the three truncation mutations are indicated. Heterochromatin and
s loss of binding to the respective structure.svirus
1 (BHV
ositionassociates with the chromatids, possibly by direct inter-
239MDV VP22action with the condensed DNA. MDV VP22 contains no
canonical nuclear import signal, suggesting that it may
enter the nucleus either attached to some other nuclear
protein or by passive diffusion. The function of the nu-
clear VP22 is unknown. A conserved characteristic of all
VP22 proteins examined to date is that they are capable
of intercellular transport, and the transported VP22 is
concentrated in the nucleus of the target cell. These
properties suggest that the nuclear VP22 may modulate
transcription or replication of host cells, perhaps prepar-
ing them for infection (Elliott and O’Hare, 1997, 2000).
MDV VP22 also appears capable of localizing to the
centrosome. VP22 associated with the centrosomes was
typically visible in cells that also exhibited nuclear VP22-
GFP fluorescence. In many cases, the nuclear fluores-
cence appeared concentrated at a position of the nu-
clear envelope opposite the labeled centrosomes. The
nuclear fluorescence then diminished in a gradient fash-
ion as a function of distance from the centrosome. This
may reflect preferential localization of heterochromatin to
regions of the nuclear envelope opposing the centro-
somes as cells proceed through early mitosis.
Despite the ability of VP22-GFP to bind microtubules,
during mitosis, only the chromatids have bound fusion
protein. VP22-GFP is absent from the microtubular mi-
totic spindle associated with mitosis. Undoubtedly, this
reflects some modification of the ability of VP22 to inter-
act with microtubules. HHV1 VP22 can be phosphory-
lated at multiple sites, and phosphorylation has been
implicated in nuclear localization (Elliott et al., 1996;
Pomeranz and Blaho, 1999). Perhaps phosphorylation
augments chromatin binding and inhibits interaction with
microtubules. Also possible are alterations in the micro-
tubules that prevent interactions with VP22. Such alter-
ations could include modifications, such as phosphory-
lation, or mitosis-specific degradation of microtubular-
associated proteins that are responsible for binding
VP22.
The carboxyl terminal truncation series demonstrates
that the microtubule, nuclear, and centrosome binding
properties of VP22 are separable. In addition, others
have shown that the region of HHV1 VP22 responsible
for intracellular transport can be distinguished from mi-
crotubule binding. Taken together, these observations
suggest that VP22 may consist of as many as four dis-
tinct domains or motifs. Despite interactions with dispar-
ate cellular compartments and structures, comparison of
MDV VP22 with the protein database by both Blast and
Psi-Blast (Altschul et al., 1997), does not reveal any sig-
nificant similarities beside other viral VP22 proteins. This
suggests that these properties of VP22 were not pirated
from cellular genes but arose during the evolution of
herpesviruses.
Alignment of VP22 proteins encoded by different her-
pesviruses indicates a core region of conservation,
spanning from MDV VP22 amino acid residues 94–180,
with significant conservation of both primary amino acidsequence (Dorange et al., 2000) and predicted secondary
structure. Outside of this region, the secondary structure is
predicted to be predominantly disordered, which is consis-
tent with the direct measurements of VP22 secondary
structure (Kueltzo et al., 2000). The deletion mutations have
mapped a regions of MDV VP22 between residues 144 and
171 and between 171 and 183 as important to heterochro-
matin and microtubule binding, respectively. With this infor-
mation, combined with the predicted motifs (Fig. 3), it may
be possible to design point mutations that affect only one of
these binding properties and resolve their relative contribu-
tions to the virus replicative cycle. Also, because at least
part of the primary sequence responsible for MDV-VP22
recognition of heterochromatin and microtubules resides in
the conserved core region, these sites may provide useful
targets for the design of future anti-herpesvirus drug ther-
apies.
MATERIALS AND METHODS
Plasmid construction
The VP22 gene and the deletion mutants were ampli-
fied from the RB1B strain of Marek’s disease virus by the
polymerase chain reaction and the primers indicated in
Table 2. The product was inserted into Bam HI-EcoRI
digested pEGFP plasmid (Clontech, Palo Alto, CA) and
the sequence of the insert determined to verify that no
errors were introduced by PCR. DNA sequencing was
done using a Perkin Elmer ABI-377 Sequencer and dye
terminators.
Transfections
Chicken embryonic fibroblasts were prepared from
10-day-old embryos using the method of Silim et al.
(1982). Cells were transfected by the calcium phosphate
technique (Graham and van der Eb, 1973) and trans-
ferred to 2-well, 25 mm slides prior to observation by
confocal microscopy.
Antibody staining
Monoclonal anti-alpha tubulin (Amersham, Arlington
Heights, IL) and anti-gamma tubulin (Sigma, St. Louis,
MO) were used at a 1:500 dilution and visualized with
Texas red coupled anti-mouse antibody (Amersham) us-
ing standard protocols (Spector et al., 1997). Images
were obtained using a Zeiss LSM 510 confocal micro-
TABLE 2
VP22 Primers
59 VP22 primer TCTAAGCTTGTTTAATATTATATCTTAGTTAC
D214 primer GATCGGATCCGATTTCAATTTCACCGCCGCGTCTT
D183 primer GATCGGATCCCTCTTCCAATAGTTTGCGGGCACAG
D171 primer GATCGGATCCCATCAAATTTGGACCCTCTTGAATG
D144 primer GATCGGATCCCGGAGGATCTTGACGCCAAAGGGCGscope.
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